Hassan Jomaa

8.0k citations
129 papers · 6.4k indexed · 1 hit paper · h-index 45

Hassan Jomaa

127 papers receiving 6.3k citations

Hit Papers

Inhibitors of the Nonmevalonate Pathway of Isoprenoid Bio...9201999202620082017250500750

Peers

Hassan Jomaa
Comparison fields: 5 of 127
  • Pharmacology 1.2k
  • Immunology 1.3k
  • Biochemistry 367
  • Public Health, Environmental and Occupational Health 1.6k
  • Molecular Biology 3.6k
Replace Martin Hintz with:
Martin Hintz Germany
Donatella Taramelli Italy
Philippe Grellier France
Vicky M. Avery Australia
Prapon Wilairat Thailand
Theresa A. Shapiro United States
Remo Perozzo Switzerland
Alexander W. Schüttelkopf United Kingdom
Po‐Huang Liang Taiwan
Vanessa Yardley United Kingdom
Hassan Jomaa relative to Martin Hintz Germany Martin Hintz's profile →
Citations per field
00.5×
Martin Hintz · 1×
Citations per year

Countries citing papers authored by Hassan Jomaa

Since Specialization
Citations

This map shows the geographic impact of Hassan Jomaa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hassan Jomaa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hassan Jomaa more than expected).

Fields of papers citing papers by Hassan Jomaa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hassan Jomaa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hassan Jomaa. The network helps show where Hassan Jomaa may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hassan Jomaa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hassan Jomaa Line = papers co-authored together Hassan Jomaa links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 201323
3 20113
4 200932
5
Benzo[c][2,7]naphthyridin-5-yl-arylamine – Phenol-Mannich-Basen vom Amodiaquin-, Cycloquin- und Pyronaridin-Typ
20076
6 200763
7
Benzo[c][2,7]naphthyridin-2-yl-, 5-yl- und 2,5-diyl-novaldiamine – Synthese und Prüfung auf Wirksamkeit gegen Malaria
200610
8
Benzo[c][2,7]naphthyridin-5-yl-amine und Benzo[h][1,6]naphthyridin-5-yl-amine - Potenzielle Antimalariamittel
200611
9
Thieno[3,2-c]chinolin-4-yl-amine - Synthese und Prüfung auf Wirksamkeit gegen Malaria
20063
10 200625
11
[Prevalence of nonmevalonate and mevalonate pathways for isoprenoid biosynthesis among bacteria of different systematic groups].
20052
12 200415
13 2003350
14 20039
15 200362
16 200296
17 2002129
18 200220
19 200170
20 200029

About Hassan Jomaa

Hassan Jomaa is a scholar working on Toxicology, Pharmacology and Organic Chemistry, having authored 129 papers that have together received 6.4k indexed citations. Recurring topics across this work include Plant biochemistry and biosynthesis (57 papers), Malaria Research and Control (38 papers), Microbial Natural Products and Biosynthesis (23 papers), Synthesis and biological activity (13 papers), Immune Cell Function and Interaction (13 papers), Bioactive Compounds and Antitumor Agents (10 papers), Synthesis and Reactivity of Heterocycles (10 papers) and Pharmacological Effects of Natural Compounds (10 papers). The work is most often cited by research in Pharmacology (1.2k citations), Immunology (1.3k citations) and Biochemistry (367 citations). Hassan Jomaa has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include Jochen Wiesner, Martin Hintz, Ewald Beck, Matthias Eberl, Martin Schlitzer, Boran Altincicek, Armin Reichenberg, Regina Ortmann, Silke Sanderbrand and Ann‐Kristin Kollas. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026